BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGR
1901
DELISTED
Avangrid, Inc.
AGR
| $168M | ﹤0.01% |
3,276,106
-1,071,839
| -25% | -$55.9M |
|
1902
Inovio Pharmaceuticals
INO
$57.3M
| $168M | ﹤0.01% |
1,514,308
+54,720
| +4% | +$5.26M |
|
1903
Option Care Health
OPCH
$3.55B
| $168M | ﹤0.01% |
7,702,222
+1,617,819
| +27% | +$31.2M |
|
|
NARI
1904
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $168M | ﹤0.01% |
1,801,335
+700,745
| +64% | +$67.9M |
|
|
NEE.PRQ
1905
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $168M | ﹤0.01% |
3,399,617
+104,609
| +3% | +$5.2M |
|
|
GES
1906
DELISTED
Guess Inc
GES
| $168M | ﹤0.01% |
6,354,291
-45,812
| -0.7% | -$1.26M |
|
1907
DNOW Inc
DNOW
$2.6B
| $168M | ﹤0.01% |
17,661,354
-74,566
| -0.4% | -$770K |
|
1908
e.l.f. Beauty
ELF
$4.87B
| $167M | ﹤0.01% |
6,158,980
-356,806
| -5% | -$10.2M |
|
|
JOYY
1909
JOYY Inc
JOYY
$3.73B
| $167M | ﹤0.01% |
2,531,294
-3,455
| -0.1% | -$293K |
|
1910
National Beverage
FIZZ
$2.95B
| $167M | ﹤0.01% |
3,534,222
-105,827
| -3% | -$5.13M |
|
1911
Coherus Oncology
CHRS
$222M
| $166M | ﹤0.01% |
12,020,457
+810,277
| +7% | +$11.5M |
|
1912
Revolve Group
RVLV
$1.86B
| $166M | ﹤0.01% |
2,411,514
+1,733,061
| +255% | +$93.1M |
|
1913
Relay Therapeutics
RLAY
$4.09B
| $166M | ﹤0.01% |
4,540,330
+741,600
| +20% | +$24.4M |
|
1914
iShares Global Financials ETF
IXG
$683M
| $166M | ﹤0.01% |
2,137,834
+1,569,835
| +276% | +$122M |
|
|
SWCH
1915
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $166M | ﹤0.01% |
7,858,174
+510,333
| +7% | +$9.78M |
|
1916
Designer Brands
DBI
$331M
| $165M | ﹤0.01% |
9,995,684
-539,770
| -5% | -$9.51M |
|
1917
iShares S&P 500 Value ETF
IVE
$49.3B
| $165M | ﹤0.01% |
1,119,067
-42,898
| -4% | -$6.32M |
|
|
FOCS
1918
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $165M | ﹤0.01% |
3,405,041
+660,777
| +24% | +$31.9M |
|
|
CVGW
1919
DELISTED
Calavo Growers
CVGW
| $165M | ﹤0.01% |
2,600,178
-92,099
| -3% | -$6.76M |
|
1920
GrowGeneration
GRWG
$88.3M
| $165M | ﹤0.01% |
3,420,183
+373,806
| +12% | +$16.4M |
|
|
VIVO
1921
DELISTED
Meridian Bioscience Inc
VIVO
| $164M | ﹤0.01% |
7,412,611
+480,066
| +7% | +$10.2M |
|
|
SI
1922
DELISTED
Silvergate Capital Corporation
SI
| $164M | ﹤0.01% |
1,450,181
-13,416
| -0.9% | -$1.52M |
|
1923
Maravai LifeSciences
MRVI
$947M
| $164M | ﹤0.01% |
3,932,207
+708,029
| +22% | +$27.4M |
|
1924
News Corp Class B
NWS
$17.2B
| $164M | ﹤0.01% |
6,730,418
-73,151
| -1% | -$1.81M |
|
1925
AXIS Capital
AXS
$7.72B
| $163M | ﹤0.01% |
3,335,834
-505,806
| -13% | -$26.8M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.